Gil Blum Analyst PerformanceSenior Biotech Analyst at Needham & Company LLCGil Blum is a stock analyst at Needham & Company LLC in the medical sector, covering 22 publicly traded companies. Over the past year, Gil Blum has issued 88 stock ratings, including buy, hold, and sell recommendations. While full access to Gil Blum's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Gil Blum's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings108 Last 4 YearsBuy Recommendations90.65% 97 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution107RatingsDistribution of strong buy, buy, hold, and sell ratings by Gil Blum.RatingPercentageCount Strong Buy0.0%0 ratings Buy90.7%97 ratings Hold8.4%9 ratings Sell0.9%0 ratingsOut of 107 total stock ratings issued by Gil Blum at Needham & Company LLC, the majority (90.7%) have been Buy recommendations, followed by 8.4% Hold and 0.9% Sell.Best & Worst CallsBest Call0000.0%CTICDec 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TSHAApr 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ22 companiesGil Blum, an analyst at Needham & Company LLC, currently covers 22 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical22 companies100.0%Gil Blum of Needham & Company LLC specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE18 companies81.8%PHARMACEUTICAL PREPARATIONS2 companies9.1%MED - DRUGS1 company4.5%MED - GENERIC DRG1 company4.5% About Gil BlumGil Blum, Ph.D., joined Needham & Company’s Biotech research team in August 2017. Gil joined Needham from Cadwalader Wickersham & Taft, New York oldest law firm where he was a Scientific Advisor in intellectual property law and prosecution. Prior to Cadwalader, Gil held a postdoctoral fellowship at the Memorial-Sloan Kettering Cancer Center, developing early drug candidates. Gil holds a Doctoral degree in Chemical Biology from Cornell University and a B.Sc. in Chemistry from Tel-Aviv University.Follow on LinkedIn Gil Blum's Ratings History at Needham & Company LLC Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRXRXRecursion Pharmaceuticals9/11/2025Reiterated Rating$4.54$8.00Buy$0.0000.00% ROIIMABI-Mab9/8/2025Reiterated Rating$4.28$6.00Buy$0.0000.00% ROIIMABI-Mab8/20/2025Boost Price Target$4.52$6.00Buy$0.0000.00% ROICELCCelcuity8/15/2025Lower Price Target$51.89$70.00Buy$0.0000.00% ROINKTXNkarta8/13/2025Reiterated Rating$1.96$10.00Buy$0.0000.00% ROIABSIAbsci8/13/2025Lower Price Target$2.97$8.00Buy$0.0000.00% ROIGBIOGeneration Bio8/13/2025Reiterated Rating$6.41$15.00Buy$0.0000.00% ROISRPTSarepta Therapeutics7/28/2025Reiterated Rating$11.93Underperform$0.0000.00% ROICELCCelcuity7/28/2025Reiterated Rating$13.77$29.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals7/24/2025Reiterated Rating$3.36Hold$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AUTLAutolus Therapeutics7/21/2025Reiterated Rating$2.57$10.00Buy$0.0000.00% ROISRPTSarepta Therapeutics7/18/2025Downgrade$16.10Hold$0.0000.00% ROISRPTSarepta Therapeutics7/17/2025Reiterated Rating$18.38$50.00Hold$0.0000.00% ROIMREOMereo BioPharma Group7/10/2025Set Price Target$2.94$5.00Buy$0.0000.00% ROIIMABI-Mab7/9/2025Reiterated Rating$2.20$5.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics7/8/2025Reiterated Rating$51.19$81.00Buy$0.0000.00% ROIRXRXRecursion Pharmaceuticals7/8/2025Reiterated Rating$5.49$8.00Buy$0.0000.00% ROITSHATaysha Gene Therapies7/1/2025Reiterated Rating$2.31$8.00Buy$0.0000.00% ROICELCCelcuity6/30/2025Reiterated Rating$12.90$29.00Buy$0.0000.00% ROIIMABI-Mab6/27/2025Boost Price Target$2.02$5.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics6/26/2025Reiterated Rating$46.56$81.00Buy$0.0000.00% ROISRPTSarepta Therapeutics6/16/2025Lower Price Target$19.73$50.00Buy$0.0000.00% ROIFATEFate Therapeutics6/12/2025Reiterated Rating$1.55Hold$0.0000.00% ROIAUTLAutolus Therapeutics6/12/2025Reiterated Rating$2.16$10.00Buy$0.0000.00% ROITSHATaysha Gene Therapies6/10/2025Reiterated Rating$2.80$8.00Buy$0.0000.00% ROITSHATaysha Gene Therapies6/2/2025Reiterated Rating$2.78$8.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals5/27/2025Downgrade$2.48$42.00Hold$0.0000.00% ROICRSPCRISPR Therapeutics5/20/2025Reiterated Rating$39.22$81.00Buy$0.0000.00% ROINKTXNkarta5/15/2025Lower Price Target$1.87$10.00Buy$0.0000.00% ROICELCCelcuity5/15/2025Reiterated Rating$10.86$29.00Buy$0.0000.00% ROIARTVArtiva Biotherapeutics5/15/2025Lower Price Target$1.81$18.00Buy$0.0000.00% ROIFATEFate Therapeutics5/14/2025Reiterated Rating$1.00Hold$0.0000.00% ROIMREOMereo BioPharma Group5/13/2025Reiterated Rating$2.45$7.00Buy$0.0000.00% ROIGBIOGeneration Bio5/8/2025Reiterated Rating$3.90$80.00Buy$0.0000.00% ROIRNACCartesian Therapeutics5/8/2025Lower Price Target$10.55$40.00Buy$0.0000.00% ROISRPTSarepta Therapeutics5/7/2025Lower Price Target$46.75$125.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics5/7/2025Lower Price Target$33.21$81.00Buy$0.0000.00% ROIRXRXRecursion Pharmaceuticals5/6/2025Lower Price Target$4.76$8.00Buy$0.0000.00% ROINRIXNurix Therapeutics4/29/2025Reiterated Rating$11.62$27.00Buy$0.0000.00% ROICELCCelcuity4/11/2025Reiterated Rating$8.65$29.00Buy$0.0000.00% ROIGBIOGeneration Bio4/10/2025Reiterated Rating$3.73$80.00Buy$0.0000.00% ROITSHATaysha Gene Therapies4/10/2025Reiterated Rating$1.20$6.00Buy$0.0000.00% ROIAUTLAutolus Therapeutics4/10/2025Reiterated Rating$1.21$10.00Buy$0.0000.00% ROIIMCRImmunocore4/10/2025Reiterated Rating$26.12$71.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics4/9/2025Reiterated Rating$31.27$84.00Buy$0.0000.00% ROINKTXNkarta4/9/2025Reiterated Rating$1.51$11.00Buy$0.0000.00% ROIMREOMereo BioPharma Group4/9/2025Reiterated Rating$1.76$7.00Buy$0.0000.00% ROIRNACCartesian Therapeutics4/9/2025Reiterated Rating$9.52$41.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals4/9/2025Reiterated Rating$4.79$42.00Buy$0.0000.00% ROINRIXNurix Therapeutics4/9/2025Lower Price Target$9.26$27.00Buy$0.0000.00% ROITCRXTScan Therapeutics4/8/2025Reiterated Rating$1.26$9.00Buy$0.0000.00% ROIRXRXRecursion Pharmaceuticals4/8/2025Reiterated Rating$4.20$11.00Buy$0.0000.00% ROIARTVArtiva Biotherapeutics4/8/2025Reiterated Rating$3.31$23.00Buy$0.0000.00% ROIIMABI-Mab4/4/2025Reiterated Rating$0.73$4.00Buy$0.0000.00% ROISRPTSarepta Therapeutics4/3/2025Lower Price Target$62.47$183.00Buy$0.0000.00% ROICELCCelcuity4/1/2025Reiterated Rating$10.11$29.00Buy$0.0000.00% ROIAUTLAutolus Therapeutics4/1/2025Lower Price Target$1.55$10.00Buy$0.0000.00% ROINKTXNkarta3/27/2025Reiterated Rating$1.37$11.00Buy$0.0000.00% ROIMREOMereo BioPharma Group3/26/2025Reiterated Rating$2.27$7.00Buy$0.0000.00% ROIARTVArtiva Biotherapeutics3/25/2025Reiterated Rating$3.91$23.00Buy$0.0000.00% ROISRPTSarepta Therapeutics3/18/2025Reiterated Rating$79.44$202.00Buy$0.0000.00% ROIGBIOGeneration Bio3/14/2025Reiterated Rating$5.12$80.00Buy$0.0000.00% ROIRNACCartesian Therapeutics3/13/2025Reiterated Rating$16.46$41.00Buy$0.0000.00% ROIGERNGeron3/12/2025Reiterated Rating$1.60$5.00Buy$0.0000.00% ROIIMCRImmunocore3/12/2025Reiterated Rating$28.42$71.00Buy$0.0000.00% ROIFATEFate Therapeutics3/6/2025Reiterated Rating$0.91Hold$0.0000.00% ROITCRXTScan Therapeutics3/5/2025Lower Price Target$1.92$9.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals2/28/2025Lower Price Target$9.40$42.00Buy$0.0000.00% ROITSHATaysha Gene Therapies2/27/2025Reiterated Rating$1.62$6.00Buy$0.0000.00% ROIIMCRImmunocore2/27/2025Reiterated Rating$30.77$71.00Buy$0.0000.00% ROIGERNGeron2/27/2025Lower Price Target$1.61$5.00Buy$0.0000.00% ROISRPTSarepta Therapeutics2/27/2025Reiterated Rating$106.86$202.00Buy$0.0000.00% ROIFOLDAmicus Therapeutics2/20/2025Reiterated Rating$9.56Hold$0.0000.00% ROICRSPCRISPR Therapeutics2/12/2025Reiterated Rating$39.62$84.00Buy$0.0000.00% ROICELCCelcuity2/6/2025Boost Price Target$12.74$29.00Buy$0.0000.00% ROIRXRXRecursion Pharmaceuticals2/6/2025Reiterated Rating$7.46$11.00Buy$0.0000.00% ROINRIXNurix Therapeutics1/29/2025Lower Price Target$19.56$28.00Buy$0.0000.00% ROIRNACCartesian Therapeutics1/27/2025Reiterated Rating$19.20$41.00Buy$0.0000.00% ROISRPTSarepta Therapeutics1/27/2025Reiterated Rating$117.98$202.00Buy$0.0000.00% ROIABSIAbsci1/22/2025Initiated Coverage$3.22$9.00Buy$0.0000.00% ROISRPTSarepta Therapeutics1/14/2025Reiterated Rating$118.43$202.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics1/14/2025Reiterated Rating$38.85$84.00Buy$0.0000.00% ROIFOLDAmicus Therapeutics1/13/2025Reiterated Rating$9.02Hold$0.0000.00% ROIMREOMereo BioPharma Group1/13/2025Reiterated Rating$3.55$7.00Buy$0.0000.00% ROIAUTLAutolus Therapeutics1/13/2025Reiterated Rating$2.24$10.00Buy$0.0000.00% ROIGERNGeron1/13/2025Boost Price Target$2.89$7.00Buy$0.0000.00% ROIRNACCartesian Therapeutics1/13/2025Reiterated Rating$17.45$41.00Buy$0.0000.00% ROIIMCRImmunocore1/10/2025Reiterated Rating$29.93$71.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
